Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity
Authors
Keywords
-
Journal
Current Opinion in Virology
Volume 51, Issue -, Pages 179-189
Publisher
Elsevier BV
Online
2021-11-06
DOI
10.1016/j.coviro.2021.10.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic
- (2021) T. R. W. Tipton et al. Nature Communications
- The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms
- (2020) Kyle O’Donnell et al. Expert Review of Vaccines
- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
- (2020) Wakako Furuyama et al. npj Vaccines
- Ebola-Specific CD8+ and CD4+ T Cell Responses in Sierra Leonean Ebola Virus Survivors with and without Post Viral Sequelae
- (2020) Stephanie M LaVergne et al. JOURNAL OF INFECTIOUS DISEASES
- Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
- (2020) Robert W. Cross et al. Nature Communications
- To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
- (2020) Amanda N. Pinski et al. Microorganisms
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
- Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
- (2019) Andrea Marzi et al. Frontiers in Immunology
- Ebola Virus Entry: From Molecular Characterization to Drug Discovery
- (2019) Cristiano Salata et al. Viruses-Basel
- Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
- (2019) Andrea R. Menicucci et al. mBio
- Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults
- (2019) Scott A Halperin et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults
- (2019) Louis Fries et al. JOURNAL OF INFECTIOUS DISEASES
- Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
- (2019) Stefanie A. Ehrhardt et al. NATURE MEDICINE
- The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
- (2019) Wenjun Zhu et al. Viruses-Basel
- Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection
- (2019) Patrick Younan et al. PLoS Pathogens
- Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
- (2019) Andrea Marzi et al. EBioMedicine
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection
- (2019) Kai J. Rogers et al. PLoS Neglected Tropical Diseases
- Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses
- (2018) Jillian H. Bradley et al. CELLULAR IMMUNOLOGY
- Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs
- (2018) Samira Locher et al. JOURNAL OF GENERAL VIROLOGY
- The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak
- (2018) Mohamed Samai et al. JOURNAL OF INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) JOURNAL OF INFECTIOUS DISEASES
- Immune Consequences of in vitro Infection of Human Peripheral Blood Leukocytes with Vesicular Stomatitis Virus
- (2018) Tomasz Tomczyk et al. Journal of Innate Immunity
- Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
- (2018) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Post-exposure treatments for Ebola and Marburg virus infections
- (2018) Robert W. Cross et al. NATURE REVIEWS DRUG DISCOVERY
- Correlates of vaccine-induced protective immunity against Ebola virus disease
- (2018) Donata Medaglini et al. SEMINARS IN IMMUNOLOGY
- A VSV-based Zika virus vaccine protects mice from lethal challenge
- (2018) Jackson Emanuel et al. Scientific Reports
- Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models
- (2018) Andrea Marzi et al. Cell Reports
- The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
- (2018) Ellen Suder et al. Human Vaccines & Immunotherapeutics
- Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
- (2018) Kuldeep Dhama et al. Frontiers in Immunology
- Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
- (2018) Joseph H Poetsch et al. JOURNAL OF INFECTIOUS DISEASES
- Perspectives towards antiviral drug discovery against Ebola virus
- (2018) Muhammad Usman Mirza et al. JOURNAL OF MEDICAL VIROLOGY
- IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
- (2018) Meili Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
- (2018) Paula Rozo-Lopez et al. Insects
- Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
- (2017) Scott A. Halperin et al. JOURNAL OF INFECTIOUS DISEASES
- Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages
- (2017) Judith Olejnik et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
- (2017) D Gray Heppner et al. LANCET INFECTIOUS DISEASES
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
- (2017) Stephen B. Kennedy et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
- (2017) Angela Huttner et al. Science Translational Medicine
- Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm
- (2017) Patrick Younan et al. mBio
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
- (2017) Anne Rechtien et al. Cell Reports
- Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial
- (2017) Selidji T. Agnandji et al. PLOS MEDICINE
- Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections
- (2017) Eleonora Cimini et al. PLoS Neglected Tropical Diseases
- Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection
- (2017) Mathieu Iampietro et al. PLoS Pathogens
- Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
- (2017) Chih-Yun Lai et al. Frontiers in Microbiology
- Developmental and Functional Control of Natural Killer Cells by Cytokines
- (2017) Yang Wu et al. Frontiers in Immunology
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
- (2017) Christine Dahlke et al. EBioMedicine
- Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection
- (2017) Andrea R. Menicucci et al. Scientific Reports
- Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona
- (2016) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Molecular mechanisms of Ebola pathogenesis
- (2016) Andrea Rivera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
- (2016) Surender Khurana et al. NATURE MEDICINE
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Two-mAb cocktail protects macaques against the Makona variant of Ebola virus
- (2016) Xiangguo Qiu et al. Science Translational Medicine
- Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment
- (2016) David K. Clarke et al. VACCINE
- Recent advances in the development of vaccines for Ebola virus disease
- (2016) Elijah Ige Ohimain VIRUS RESEARCH
- Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
- (2016) Jesper Pallesen et al. Nature Microbiology
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick
- (2015) Lilin Lai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- VSVΔG/EBOV GP-Induced Innate Protection Enhances Natural Killer Cell Activity to Increase Survival in a Lethal Mouse Adapted Ebola Virus Infection
- (2015) Kinola J.N. Williams et al. VIRAL IMMUNOLOGY
- Less Is More: Ebola Virus Surface Glycoprotein Expression Levels Regulate Virus Production and Infectivity
- (2014) Gopi S. Mohan et al. JOURNAL OF VIROLOGY
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
- (2014) Chad E. Mire et al. PLoS One
- Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
- (2014) Beatriz Escudero-Pérez et al. PLoS Pathogens
- Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling Pathways
- (2013) Natarajan Ayithan et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
- (2013) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- NK Cell-Derived Interferon-γ Orchestrates Cellular Dynamics and the Differentiation of Monocytes into Dendritic Cells at the Site of Infection
- (2012) Romina S. Goldszmid et al. IMMUNITY
- The Immune Response to a Vesicular Stomatitis Virus Vaccine Vector Is Independent of Particulate Antigen Secretion and Protein Turnover Rate
- (2012) Melissa A. Cobleigh et al. JOURNAL OF VIROLOGY
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
- (2012) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus
- (2012) Gopi S. Mohan et al. PLoS Pathogens
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus
- (2011) K. S. Brown et al. JOURNAL OF VIROLOGY
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Progress in filovirus vaccine development: evaluating the potential for clinical use
- (2010) Darryl Falzarano et al. Expert Review of Vaccines
- Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
- (2010) Nadia Wauquier et al. IMMUNOGENETICS
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
- (2010) Nadia Wauquier et al. PLoS Neglected Tropical Diseases
- Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK and TBK-1
- (2009) K. C. Prins et al. JOURNAL OF VIROLOGY
- Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1
- (2009) A. Okumura et al. JOURNAL OF VIROLOGY
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
- (2009) Xiangguo Qiu et al. PLoS One
- Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
- (2009) Rachel L. Kaletsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIG-I activation inhibits ebolavirus replication
- (2009) Christina F. Spiropoulou et al. VIROLOGY
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- (2008) Thomas W. Geisbert et al. VACCINE
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started